CRP and nutritional deficiency disease: This confirms the role of CRP elevation as an indicator of active disease and its potential relevance as an inclusion criterion in trials.18–21 The data also support the notion that the presence of muscle weakness may include patients with overt myositis/myopathy, as well as patients with gastrointestinal problems being more likely to have malnutrition and consecutive muscle weakness.